Llwytho...
The novel, potent and highly selective 5‐HT(4) receptor agonist YH12852 significantly improves both upper and lower gastrointestinal motility
BACKGROUND AND PURPOSE: 5‐HT(4) receptor agonists have been shown to be effective at treating various gastrointestinal tract disorders. However, a lack of selectivity against off‐targets has been a limiting factor for their clinical use. EXPERIMENTAL APPROACH: The binding affinity and selectivity of...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Br J Pharmacol |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5773938/ https://ncbi.nlm.nih.gov/pubmed/29139561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14096 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|